Anti-Germ & Medentech
Entry
2015
Hold
2yr
Exit
2017
Who owns Anti-Germ & Medentech?
Anti-Germ & Medentech is a German Industrials company, now owned by Hypred, which acquired it in 2017 from Paragon Partners.
Hand-verified · updated 2026-07-02
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Hypred
Exit Year
2017
More from Paragon Fund II
Other portfolio companies in the same fund.
Apontis Pharma
Exited 2024
Pharma
Germany· 2018
Germany· 2018to Zentiva
Asic Robotics
Exited 2026
Industrials
Switzerland· 2018
Switzerland· 2018to Renaissance Anlagestiftung
inprotec
Exited 2022
IndustrialsGermany· 2018
Germany· 2018to International Chemical Investors Group
Unicepta
Exited 2024
Business ServicesGermany· 2018
Germany· 2018to Stagwell
chicco di caffe
Exited 2023
Business ServicesGermany· 2017
Germany· 2017to WISAG Catering
Condecta
Exited 2024
Business ServicesSwitzerland· 2017
Switzerland· 2017to Swiss Life Asset Managers
More PE-backed in Industrials
Comparable industrials deals from other GPs.
UK
Finland
USQuestions
Who owns Anti-Germ & Medentech?
Anti-Germ & Medentech is now owned by Hypred, which acquired it in 2017 from Paragon Partners.
When did Hypred acquire Anti-Germ & Medentech?
Hypred acquired Anti-Germ & Medentech in 2017, buying from Paragon Partners.
Who did Anti-Germ & Medentech sell to?
Paragon Partners sold Anti-Germ & Medentech to Hypred in 2017 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue